Li‐Ping Ge

984 total citations · 1 hit paper
34 papers, 705 citations indexed

About

Li‐Ping Ge is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Li‐Ping Ge has authored 34 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Li‐Ping Ge's work include Lung Cancer Treatments and Mutations (7 papers), Cell death mechanisms and regulation (4 papers) and Sulfur Compounds in Biology (4 papers). Li‐Ping Ge is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Cell death mechanisms and regulation (4 papers) and Sulfur Compounds in Biology (4 papers). Li‐Ping Ge collaborates with scholars based in China, United States and Hong Kong. Li‐Ping Ge's co-authors include Yi‐Zhou Jiang, Zhi‐Ming Shao, Da‐Qiang Li, Yun‐Song Yang, Xi Jin, Ping Chen, Chunhua Dai, Xiao‐En Xu, Qiuzhuang Sun and Qiang Yu and has published in prestigious journals such as Oncogene, Biochemical and Biophysical Research Communications and Nature Chemistry.

In The Last Decade

Li‐Ping Ge

33 papers receiving 699 citations

Hit Papers

Comprehensive metabolomics expands precision medicine for... 2022 2026 2023 2024 2022 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
    2022 202 citations Yi Xiao, Ding Ma et al. Cell Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li‐Ping Ge China 15 343 253 216 171 61 34 705
Ralph W. de Vere White United States 17 394 1.1× 229 0.9× 166 0.8× 223 1.3× 52 0.9× 24 952
Xun Bao United States 16 503 1.5× 299 1.2× 213 1.0× 187 1.1× 25 0.4× 42 953
Gek San Tan Singapore 12 346 1.0× 101 0.4× 223 1.0× 99 0.6× 101 1.7× 19 709
Xiang‐Lin Tan United States 14 490 1.4× 316 1.2× 195 0.9× 107 0.6× 132 2.2× 25 905
Chengyong Dong China 17 387 1.1× 201 0.8× 251 1.2× 100 0.6× 25 0.4× 29 721
Aoife M. Shannon Ireland 14 350 1.0× 222 0.9× 355 1.6× 142 0.8× 22 0.4× 27 964
Junya Ning China 13 396 1.2× 156 0.6× 207 1.0× 88 0.5× 147 2.4× 31 836
Nianhua Ding China 11 202 0.6× 223 0.9× 100 0.5× 74 0.4× 39 0.6× 17 565
Ruth Gutiérrez Spain 7 341 1.0× 101 0.4× 250 1.2× 107 0.6× 34 0.6× 11 715

Countries citing papers authored by Li‐Ping Ge

Since Specialization
Citations

This map shows the geographic impact of Li‐Ping Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Ping Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Ping Ge more than expected).

Fields of papers citing papers by Li‐Ping Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐Ping Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Ping Ge. The network helps show where Li‐Ping Ge may publish in the future.

Co-authorship network of co-authors of Li‐Ping Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Ping Ge. A scholar is included among the top collaborators of Li‐Ping Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Ping Ge. Li‐Ping Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ge, Li‐Ping & Yi‐Zhou Jiang. (2025). Combination of autophagy inhibitors with high-dose CDK4/6 inhibitors offers new hope for advanced HR+/HER2− breast cancer. Med. 6(5). 100571–100571. 1 indexed citations
2.
Ge, Li‐Ping, Jianrong Li, Ping Li, et al.. (2024). Psychological Stress and Its Correlations to Patients with Acute Lymphedema After Breast Cancer Surgery. Breast Cancer Targets and Therapy. Volume 16. 867–876.
3.
Ge, Li‐Ping, Xi Jin, Ding Ma, et al.. (2024). ZNF689 deficiency promotes intratumor heterogeneity and immunotherapy resistance in triple-negative breast cancer. Cell Research. 34(1). 58–75. 23 indexed citations
4.
Lü, Xiaolin, Li‐Ping Ge, Zhaopei Liu, et al.. (2024). CXCR6 expression predicts prognosis and immunotherapeutic benefit in muscle-invasive bladder cancer. Frontiers in Oncology. 14. 1498579–1498579. 1 indexed citations
5.
Wang, Zi-Yu, Li‐Ping Ge, Yang Ouyang, Xi Jin, & Yi‐Zhou Jiang. (2024). Targeting transposable elements in cancer: developments and opportunities. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(5). 189143–189143. 4 indexed citations
6.
Hu, Qinqin, Li‐Ping Ge, Qiang Shi, et al.. (2023). DNAzyme-based faithful probing and pulldown to identify candidate biomarkers of low abundance. Nature Chemistry. 16(1). 122–131. 22 indexed citations
7.
Xiao, Yi, Ding Ma, Yun‐Song Yang, et al.. (2022). Comprehensive metabolomics expands precision medicine for triple-negative breast cancer. Cell Research. 32(5). 477–490. 202 indexed citations breakdown →
8.
Ge, Li‐Ping, Xi Jin, Yun‐Song Yang, et al.. (2021). Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor. Oncogene. 40(12). 2323–2334. 18 indexed citations
9.
Jiang, Wenjing, et al.. (2020). Finding an efficient tetramethylated hydroxydiethylene of resveratrol analogue for potential anticancer agent. BMC Chemistry. 14(1). 5 indexed citations
10.
11.
Jin, Xi, Li‐Ping Ge, Da‐Qiang Li, et al.. (2020). LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer. Molecular Cancer. 19(1). 87–87. 70 indexed citations
12.
Liu, Xiyu, Jiang Wang, Ding Ma, et al.. (2020). SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer. Theranostics. 10(24). 10940–10956. 32 indexed citations
13.
Ge, Li‐Ping, Xiyu Liu, Yi Xiao, et al.. (2018). Clinicopathological characteristics and treatment outcomes of occult breast cancer: a SEER population-based study. Cancer Management and Research. Volume 10. 4381–4391. 25 indexed citations
14.
Ge, Li‐Ping, et al.. (2014). Prognostic and predictive value of plasma D-dimer in advanced non-small cell lung cancer patients undergoing first-line chemotherapy. Clinical & Translational Oncology. 17(1). 57–64. 26 indexed citations
15.
16.
Li, Jian, et al.. (2014). Value of fibrinogen and D-dimer in predicting recurrence and metastasis after radical surgery for non-small cell lung cancer. Medical Oncology. 31(7). 22–22. 48 indexed citations
17.
Li, Jian, et al.. (2012). Evaluation of pleural fluid survivin and XIAP for the diagnosis of malignant pleural effusion. Tumor Biology. 33(5). 1803–1810. 9 indexed citations
18.
19.
20.
Zhan, Jinbiao, et al.. (2004). A trans-Golgi network retention signal YQRL fused to ricin A chain significantly enhances its cytotoxicity. Biochemical and Biophysical Research Communications. 313(4). 1053–1057. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ralph W. de Vere White Breakdown of academic impact, for papers by Xun Bao Breakdown of academic impact, for papers by Gek San Tan Breakdown of academic impact, for papers by Xiang‐Lin Tan Breakdown of academic impact, for papers by Chengyong Dong Breakdown of academic impact, for papers by Aoife M. Shannon Breakdown of academic impact, for papers by Junya Ning Breakdown of academic impact, for papers by Nianhua Ding Breakdown of academic impact, for papers by Ruth Gutiérrez
Rankless by CCL
2026